Based on the forecasted data, the annual usage of Renin-Angiotensin System medicines in the Netherlands shows a consistent year-on-year increase:
- 2024: 143.5 units (DDD/Thousand Persons/Day)
- 2025: 143.8 units (+0.21% YoY)
- 2026: 144.0 units (+0.14% YoY)
- 2027: 144.2 units (+0.14% YoY)
- 2028: 144.4 units (+0.14% YoY)
The compound annual growth rate (CAGR) over the last 5 years is approximately 0.14% per year.
Future Trends to Watch
While the annual growth rate is modest, factors such as advancements in antihypertensive therapies, demographic changes, and healthcare policies may impact these trends. Continuous monitoring of healthcare developments and population health metrics will be essential for accurate forecasting.
